Subscribe to RSS
Clinical Profile and Outcomes of Treatment in Gastric Cancer in Young Patients in India
Introduction Gastric cancer poses an enormous burden across the globe and India in terms of cancer-related mortality. There is paucity of epidemiological and survival data among young gastric cancer patients in India. In this study, we retrospectively analyzed the general characteristics, clinical profile, and survival data of gastric cancer in young patients < 30 years at tertiary care institution at New Delhi, India.
Materials and Methods Young gastric cancer patients (≤30 years) who were registered over a period of 7 years (2010–2017) were analyzed at a tertiary care center. Total of 2,735 patients of gastric cancers were registered out of which 70 cases were younger than 30 years, of which 63 patients were available for final analysis and data was missing for the remaining 7 cases. All patients underwent standard diagnostic and staging investigation and were staged as per American Joint Committee on Cancer 7 staging system. Lymph node ratio was calculated as number of positive nodes by the number of lymph nodes removed and were categorized as ≤0.6 and >0.6. Minimum follow-up of 1 year was required for inclusion in the study. Twelve patients were lost to follow-up and were not included for survival analysis.
Results Younger patients (≤30 years) with gastric cancer were 2.5% of total gastric cancer patients. Mean age was 24.9 years with males being involved twice as commonly as females (2.15:1). Positive family history was present in 14.2% patients and smoking was present in 57.1% patients. Metastatic disease at presentation was present in 69.8% patients, while only 6.4% patients presented with stage I/II disease. Fourteen patients underwent surgery, out of which six patients underwent partial gastrectomy and remaining eight underwent total gastrectomy with D2 nodal dissection. Median overall survival was 10.8 months (8.8–12.8) and 2-year overall survival was 15.1%.
Conclusion Incidence of stomach cancer in young patients is more than expected and more than global average in India. Most of these young patients are presenting in advanced stage and survival is poor compared with typical aged patients
The manuscript has been read and approved by all the authors, that the requirements for authorship stated earlier in this document have been met, and that each author believes that the manuscript represents honest work.
Article published online:
18 April 2022
© 2022. Spring Hope Cancer Foundation & Young Oncologist Group of Asia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
- 1 Miller KD, Goding Sauer A, Ortiz AP. et al. Cancer statistics for Hispanics/Latinos, 2018. CA Cancer J Clin 2018; 68 (06) 425-445
- 2 Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60 (05) 277-300
- 3 Etemadi A, Safiri S, Sepanlou SG. et al; GBD 2017 Stomach Cancer Collaborators. The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2020; 5 (01) 42-54
- 4 Dikshit RP, Mathur G, Mhatre S, Yeole BB. Epidemiological review of gastric cancer in India. Indian J Med Paediatr Oncol 2011; 32 (01) 3-11
- 5 Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006; 12 (03) 354-362
- 6 Tso PL, Bringaze III WL, Dauterive AH, Correa P, Cohn Jr I. Gastric carcinoma in the young. Cancer 1987; 59 (07) 1362-1365
- 7 Theuer CP, Kurosaki T, Taylor TH, Anton-Culver H. Unique features of gastric carcinoma in the young: a population-based analysis. Cancer 1998; 83 (01) 25-33
- 8 Tavares A, Gandra A, Viveiros F, Cidade C, Maciel J. Analysis of clinicopathologic characteristics and prognosis of gastric cancer in young and older patients. Pathol Oncol Res 2013; 19 (01) 111-117
- 9 Bani-Hani KE. Clinicopathological comparison between young and old age patients with gastric adenocarcinoma. Int J Gastrointest Cancer 2005; 35 (01) 43-52
- 10 Correa P. The biological model of gastric carcinogenesis. IARC Sci Publ 2004; (157) 301-310
- 11 Lynch HT, Grady W, Suriano G, Huntsman D. Gastric cancer: new genetic developments. J Surg Oncol 2005; 90 (03) 114-133 , discussion 133
- 12 Huntsman DG, Carneiro F, Lewis FR. et al. Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J Med 2001; 344 (25) 1904-1909
- 13 Suriano G, Yew S, Ferreira P. et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res 2005; 11 (15) 5401-5409
- 14 Ramos-De la Medina A, Salgado-Nesme N, Torres-Villalobos G, Medina-Franco H. Clinicopathologic characteristics of gastric cancer in a young patient population. J Gastrointest Surg 2004; 8 (03) 240-244
- 15 De B, Rhome R, Jairam V. et al. Gastric adenocarcinoma in young adult patients: patterns of care and survival in the United States. Gastric Cancer 2018; 21 (06) 889-899
- 16 Celen O, Yildirim E, Berberoglu U. Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol 2007; 96 (02) 95-101
- 17 Inoue K, Nakane Y, Iiyama H. et al. The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 2002; 9 (01) 27-34
- 18 Marchet A, Mocellin S, Ambrosi A. et al; Italian Research Group for Gastric Cancer (IRGGC). The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients. Ann Surg 2007; 245 (04) 543-552
- 19 Nitti D, Marchet A, Olivieri M. et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol 2003; 10 (09) 1077-1085
- 20 Huang CM, Lin JX, Zheng CH. et al. Prognostic impact of metastatic lymph node ratio on gastric cancer after curative distal gastrectomy. World J Gastroenterol 2010; 16 (16) 2055-2060
- 21 Saito H, Fukumoto Y, Osaki T. et al. Prognostic significance of the ratio between metastatic and dissected lymph nodes (n ratio) in patients with advanced gastric cancer. J Surg Oncol 2008; 97 (02) 132-135
- 22 Xu DZ, Geng QR, Long ZJ. et al. Positive lymph node ratio is an independent prognostic factor in gastric cancer after d2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 2009; 16 (02) 319-326
- 23 Chung HW, Noh SH, Lim JB. Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol 2010; 16 (02) 256-263
- 24 Lai JF, Kim S, Li C. et al. Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection. Ann Surg Oncol 2008; 15 (05) 1464-1469
- 25 Theuer CP, de Virgilio C, Keese G. et al. Gastric adenocarcinoma in patients 40 years of age or younger. Am J Surg 1996; 172 (05) 473-476 , discussion 476–477